Axonics, Inc. (NasdaqGM: AXNX)
Health Care · Health Care Equipment & Supplies · US
$—
— today · — 1Y
Axonics, Inc. (NasdaqGM: AXNX) operates in the Health Care Equipment & Supplies industry within the Health Care sector.
Tweenvest scores Axonics, Inc. across four factors: quality 63/100, value 32/100, growth 100/100. Its strongest factor is growth.
AXNX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $431.90M
- P/E
- —
- EPS
- -0.11
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 797
- Next earnings
- —
About Axonics, Inc.
Axonics, Inc. is a medical device firm that focuses on developing and bringing to market sacral neuromodulation (SNM) solutions. These advanced SNM systems are designed to address a range of medical conditions, such as overactive bladder (including urinary urge incontinence and frequent urges to urinate), alongside fecal incontinence and non-obstructive urinary retention. The company's flagship rechargeable SNM System, known as r-SNM, operates by delivering gentle electrical impulses to specific sacral nerves, aiming to restore regular communication between the brain and the bladder or bowel, thereby lessening the symptoms of their dysfunction. Beyond its SNM portfolio, Axonics also provides Bulkamid, a urethral bulking agent for managing stress urinary incontinence in women. The firm distributes its offerings both through its dedicated sales team and a network of distributors across the United States, the United Kingdom, Germany, the Netherlands, the Nordic region, and other international markets. Established in 2012 and headquartered in Irvine, California, the company was initially known as Axonics Modulation Technologies, Inc., before officially changing its name to Axonics, Inc. in March 2021.
- ISIN
- US05465P1012
- Founded
- 2012
- Listed since
- Oct 31, 2018
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cue Health Inc.OTCPK: HLTH.Q | $159.00 | $0.00 | -99.00% |
| SmileDirectClub, Inc.OTCPK: SDCC.Q | $134.00 | $0.00 | -90.00% |
| CVR Medical Corp.OTCPK: CRRV.F | $132.00 | $— | — |
| Cognetivity Neurosciences Ltd.OTCPK: CGNS.F | $94.00 | $0.00 | — |
| IMRIS Inc.OTCPK: IMRS.Q | $63.00 | $0.00 | — |
| Nemaura Medical Inc.OTCPK: NMRD | $40.00 | $0.00 | -99.00% |
| Imagin Medical Inc.OTCPK: IMEX.F | $11.00 | $— | — |
| DIH Holding US, Inc.OTCPK: DHAI | $2.00 | $0.00 | — |
Figures last refreshed Oct 11, 2026.